JPS6438045A - Alkoxy substituted dihydrobenzopyran-2-carboxylate derivative - Google Patents

Alkoxy substituted dihydrobenzopyran-2-carboxylate derivative

Info

Publication number
JPS6438045A
JPS6438045A JP63130037A JP13003788A JPS6438045A JP S6438045 A JPS6438045 A JP S6438045A JP 63130037 A JP63130037 A JP 63130037A JP 13003788 A JP13003788 A JP 13003788A JP S6438045 A JPS6438045 A JP S6438045A
Authority
JP
Japan
Prior art keywords
alkoxy substituted
carboxylate derivative
dihydrobenzopyran
substituted dihydrobenzopyran
carboxylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63130037A
Other languages
English (en)
Other versions
JP2758902B2 (ja
Inventor
Ueikufuiirudo Dojiyuri Suteban
Rarii Shiyon Robaato
Shiu Toujii Yu Sutera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of JPS6438045A publication Critical patent/JPS6438045A/ja
Application granted granted Critical
Publication of JP2758902B2 publication Critical patent/JP2758902B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP63130037A 1987-05-29 1988-05-27 アルコキシ置換ジヒドロベンゾピラン−２−カルボキシレート誘導体 Expired - Fee Related JP2758902B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5713687A 1987-05-29 1987-05-29
US057136 1987-05-29
US188708 1988-05-12
US07/188,708 US4889871A (en) 1987-05-29 1988-05-12 Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives

Publications (2)

Publication Number Publication Date
JPS6438045A true JPS6438045A (en) 1989-02-08
JP2758902B2 JP2758902B2 (ja) 1998-05-28

Family

ID=26736113

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63130037A Expired - Fee Related JP2758902B2 (ja) 1987-05-29 1988-05-27 アルコキシ置換ジヒドロベンゾピラン−２−カルボキシレート誘導体

Country Status (17)

Country Link
US (1) US4889871A (ja)
EP (1) EP0292977B1 (ja)
JP (1) JP2758902B2 (ja)
KR (1) KR880013914A (ja)
AU (1) AU611153B2 (ja)
CA (1) CA1337660C (ja)
DE (1) DE3864582D1 (ja)
DK (1) DK290188A (ja)
ES (1) ES2051796T3 (ja)
FI (1) FI882505A (ja)
GR (1) GR3003177T3 (ja)
IE (1) IE60687B1 (ja)
IL (1) IL86502A (ja)
NO (1) NO171063C (ja)
NZ (1) NZ224807A (ja)
PH (1) PH26153A (ja)
PT (1) PT87603B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012783A1 (en) * 1991-12-27 1993-07-08 Kureha Chemical Industry Co., Ltd. Oleaginous ointment
JPH0625764A (ja) * 1992-07-08 1994-02-01 Sumitomo Metal Ind Ltd フェロスクラップ中の銅の除去・回収方法

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300404A3 (en) * 1987-07-20 1990-07-18 G.D. Searle & Co. Di-and tetrahydronapthyl anti-allergy agents
IL89713A0 (en) * 1988-03-29 1989-09-28 Ciba Geigy Ag Novel alkanophenones
MA21528A1 (fr) * 1988-04-06 1989-12-31 Lipha Composants substituants du flavonoide, leurs sels, leurs manufactures et produits contenant ces matieres .
US5219883A (en) * 1988-05-20 1993-06-15 G. D. Searle & Co. 2,2-di-substituted benzopyran leukotriene-D4 antagonists
US4931574A (en) * 1988-08-23 1990-06-05 Hoffmann-La Roche Inc. Process for the preparation of benzopyrans
WO1990012010A1 (en) * 1989-04-07 1990-10-18 Pfizer Inc. Substituted chromans in the treatment of asthma, arthritis and related diseases
US5212198A (en) * 1990-05-10 1993-05-18 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5073562A (en) * 1990-05-10 1991-12-17 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5192782A (en) * 1990-05-10 1993-03-09 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5051438A (en) * 1990-05-16 1991-09-24 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use
US5124350A (en) * 1990-06-28 1992-06-23 G. D. Searle & Co. Leukotriene b4 antagonists
FR2665159B1 (fr) * 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
AU8641991A (en) * 1990-09-10 1992-03-30 Rhone-Poulenc Rorer International (Holdings) Inc. Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
US5488160A (en) * 1991-06-11 1996-01-30 Ciba-Geigy Corporation Amidino compounds, their manufacture and method of treatment
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
US5273999A (en) * 1991-09-10 1993-12-28 Hoffmann-La Roche Inc. Carboxylic acid leukotriene B4 antagonists
JP2813464B2 (ja) * 1992-01-23 1998-10-22 フアイザー・インコーポレイテツド ベンゾピラン及び関連ｌｔｂ▲下４▼アンタゴニスト
PT902013E (pt) * 1992-02-05 2002-06-28 Boehringer Ingelheim Pharma Novos derivados amidina sua preparacao e utilizacao como medicamento com actividade antagonista de ltb4
US5352690A (en) * 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
US5324743A (en) * 1992-12-10 1994-06-28 Eli Lilly And Company Leukotriene B4 antagonists
DE4309285A1 (de) * 1993-03-23 1994-09-29 Boehringer Ingelheim Kg Heterocyclen enthaltende Amidinderivate, ihre Herstellung und Verwendung
US5380740A (en) * 1993-04-28 1995-01-10 G. D. Searle & Co. Anti-inflammatory compounds, compositions and method of use thereof
ES2084547B1 (es) * 1993-07-12 1997-01-16 Pfizer Antagonistas benzopiranicos y relacionados de leucotrieno b4.
US5457124A (en) * 1993-12-07 1995-10-10 Hoffmann-La Roche Inc. Carboxylic acid Leukotriene B4 antagonists
WO1995032201A1 (en) * 1994-05-25 1995-11-30 G.D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-sulfonimides derivatives, their preparation and their use as leukotriene b4 antagonists
US5516917A (en) * 1994-06-08 1996-05-14 G. D. Searle & Co. Leukotriene B4 antagonists
US5543428A (en) * 1994-08-31 1996-08-06 Eli Lilly And Company Method for treating resistant tumors
CA2198752A1 (en) 1994-08-31 1996-03-07 Jason Scott Sawyer Methods for identifying and treating resistant tumors
KR100232340B1 (ko) * 1994-10-13 1999-12-01 디. 제이. 우드, 스피겔 알렌 제이 류코트리엔 b4(ltb4) 길항물질로서의 벤조피란 및 벤조-축합된 화합물
MX9702731A (es) * 1994-10-13 1997-06-28 Pfizer Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos.
IL121931A (en) * 1996-10-17 2000-02-17 Pfizer Pharmaceutical compositions for preventing allograft rejection
JP2002523457A (ja) * 1998-08-28 2002-07-30 バイオメディシンズ，インコーポレイティド インターロイキン−２の有害反応を緩和する方法
US6436987B1 (en) 2000-06-08 2002-08-20 Pfizer Inc. Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid
JP2004513090A (ja) * 2000-09-27 2004-04-30 メルク　エンド　カムパニー　インコーポレーテッド 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体
EP1347755A2 (en) 2000-10-31 2003-10-01 Merck & Co., Inc. Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
US20040242676A1 (en) * 2003-05-30 2004-12-02 Alessi Thomas R. Method of mitigating the adverse effects of IL-2
US8093253B2 (en) * 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006245A (en) * 1971-07-29 1977-02-01 Fisons Limited Chemical compounds
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
ATE14579T1 (de) * 1979-03-20 1985-08-15 Fisons Plc Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
US4474788A (en) * 1981-11-12 1984-10-02 Fisons Plc Anti-SRSA quinoline carboxylic acid derivatives
ZA844519B (en) * 1983-06-24 1985-02-27 Hoffmann La Roche Dihydrobenzopyran derivatives
AU548450B2 (en) * 1983-08-08 1985-12-12 G.D. Searle & Co. Substituted dihydrobenzopyrans
US4665203A (en) * 1983-08-08 1987-05-12 G. D. Searle & Co. Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
US4546194A (en) * 1984-05-29 1985-10-08 G. D. Searle & Co. Substituted chromanon-2-yl alkanols and derivatives thereof
DE3569062D1 (en) * 1985-06-28 1989-04-27 Ibm Shadow mask colour crt with enhanced resolution and/or brightness
ZA873745B (en) * 1986-06-04 1988-10-26 Daiichi Seiyaku Co Benzopyran derivatives
US4885309A (en) * 1986-08-01 1989-12-05 Hoffmann-La Roche Inc. Therapeutic treatment of leukotriene-mediated dermal inflammation by topical administration of 3,4-dihydro-2H-1-benzopyran derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993012783A1 (en) * 1991-12-27 1993-07-08 Kureha Chemical Industry Co., Ltd. Oleaginous ointment
JPH0625764A (ja) * 1992-07-08 1994-02-01 Sumitomo Metal Ind Ltd フェロスクラップ中の銅の除去・回収方法

Also Published As

Publication number Publication date
CA1337660C (en) 1995-11-28
JP2758902B2 (ja) 1998-05-28
DK290188A (da) 1988-11-30
NO171063B (no) 1992-10-12
NO171063C (no) 1993-01-20
AU1668188A (en) 1988-12-01
EP0292977B1 (en) 1991-09-04
FI882505A0 (fi) 1988-05-27
FI882505A (fi) 1988-11-30
IE60687B1 (en) 1994-08-10
NZ224807A (en) 1991-03-26
GR3003177T3 (en) 1993-02-17
US4889871A (en) 1989-12-26
NO882317L (no) 1988-11-30
ES2051796T3 (es) 1994-07-01
DK290188D0 (da) 1988-05-27
EP0292977A1 (en) 1988-11-30
AU611153B2 (en) 1991-06-06
IL86502A0 (en) 1988-11-15
NO882317D0 (no) 1988-05-26
IL86502A (en) 1994-07-31
PH26153A (en) 1992-03-18
KR880013914A (ko) 1988-12-22
DE3864582D1 (de) 1991-10-10
PT87603A (pt) 1988-06-01
IE881611L (en) 1988-11-29
PT87603B (pt) 1992-12-31

Similar Documents

Publication Publication Date Title
JPS6438045A (en) Alkoxy substituted dihydrobenzopyran-2-carboxylate derivative
JPS6422857A (en) Azolylmethyl-cyclopropyl derivative
JPS6434950A (en) N-aminobutyl-n-phenylarylamide derivative
EP0318704A3 (en) 3-cyano-4-phenyl-pyrrole derivatives
GB8815258D0 (en) Thiorea derivatives
EP0305322A3 (en) Isoxazole-beta-carboline derivatives
JPS6471871A (en) Biarylalkylimidazole derivative
JPS6426562A (en) Hydroxyethylazolyl derivative
JPS6431785A (en) Substituted thienoimidazole derivative
IL88134A0 (en) Substituted azacyclohexyl derivatives
JPS6426569A (en) 1-phenoxy-3-triazolyl-1-hexene derivative
GB2205829B (en) 2-aryl-4-isoxazolin-3-one derivatives
GB8709887D0 (en) Alkyl azodicarboxylates
EP0322164A3 (en) Ethanolamie derivatives
GB8705601D0 (en) Oxo-isoindolinyl derivatives
ZA887966B (en) Substituted azacyclohexyl derivatives
GB8726272D0 (en) 4-demethoxy anthra-cycline derivatives
JPS6426561A (en) Azolylmethyl-cyclopropylcarbinol derivative
GB2200910B (en) Thiopilocarpine derivatives
JPS6440473A (en) Thermotropic di-s-triazine derivative
JPS6470492A (en) Substituted thienoimidazole derivative
GB8704236D0 (en) Anthracycline-oestrone derivatives
GB8700016D0 (en) Quinolizinone derivatives
JPS6445379A (en) Thiapentaneamide derivative
GB8707988D0 (en) Alkoxy derivatives

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees